These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 11495284

  • 1. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S, Mandal A, Duttagupta S.
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [Abstract] [Full Text] [Related]

  • 2. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D.
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [Abstract] [Full Text] [Related]

  • 3. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R.
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [Abstract] [Full Text] [Related]

  • 4. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 5. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M, Sahasrabuddhe AA, Singh N, Gupta SK, Sundar S, Dube A.
    Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
    [Abstract] [Full Text] [Related]

  • 6. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH, Gasim Khalil EA, Theander TG, Kharazmi A, Omer SA, Ibrahim ME.
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [Abstract] [Full Text] [Related]

  • 7. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

  • 8. Novel mechanism of drug resistance in kala azar field isolates.
    Singh N, Singh RT, Sundar S.
    J Infect Dis; 2003 Aug 15; 188(4):600-7. PubMed ID: 12898450
    [Abstract] [Full Text] [Related]

  • 9. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
    Valiathan R, Dubey ML, Mahajan RC, Malla N.
    Exp Parasitol; 2006 Oct 15; 114(2):103-8. PubMed ID: 16616137
    [Abstract] [Full Text] [Related]

  • 10. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S.
    Int J Parasitol; 2011 Nov 15; 41(13-14):1311-21. PubMed ID: 21920365
    [Abstract] [Full Text] [Related]

  • 11. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV, Gurumurthy S, Kuhls K, Bhandari V, Schnonian G, Salotra P.
    Parasitol Res; 2012 Oct 15; 111(4):1559-68. PubMed ID: 22752721
    [Abstract] [Full Text] [Related]

  • 12. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
    Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926
    [Abstract] [Full Text] [Related]

  • 13. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Jun 04; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 14. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M, Majumder HK, Sundar S, Bhaduri AN.
    Med Sci Monit; 2005 Jul 04; 11(7):BR220-7. PubMed ID: 15990683
    [Abstract] [Full Text] [Related]

  • 15. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD.
    Hamad SH, Khalil EA, Musa AM, Ibrahim ME, Younis BM, Elfaki ME, El-Hassan AM, Leishmaniasis Research Group, Sudan.
    Exp Parasitol; 2010 Aug 04; 125(4):389-93. PubMed ID: 20346944
    [Abstract] [Full Text] [Related]

  • 16. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK, Rai S, Ashutosh, Ravinder, Gupta S, Sundar S, Goyal N.
    Am J Trop Med Hyg; 2007 Apr 04; 76(4):681-8. PubMed ID: 17426170
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
    Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P.
    Int J Antimicrob Agents; 2010 Jul 04; 36(1):50-7. PubMed ID: 20427152
    [Abstract] [Full Text] [Related]

  • 18. Studies on stibanate unresponsive isolates of Leishmania donovani.
    Bhattacharyya A, Mukherjee M, Duttagupta S.
    J Biosci; 2002 Sep 04; 27(5):503-8. PubMed ID: 12381874
    [Abstract] [Full Text] [Related]

  • 19. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
    Ouakad M, Vanaerschot M, Rijal S, Sundar S, Speybroeck N, Kestens L, Boel L, De Doncker S, Maes I, Decuypere S, Dujardin JC.
    Parasitology; 2011 Sep 04; 138(11):1392-9. PubMed ID: 21819638
    [Abstract] [Full Text] [Related]

  • 20. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK, Das P.
    Exp Parasitol; 2009 Jan 04; 121(1):69-75. PubMed ID: 18948098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.